Premium
P4‐428: Mechanism of action of new Alzheimer's therapeutic in phase III clinical trials
Author(s) -
Mullan Michael,
Bachmeier Corbin,
AitGhezala Ghania,
BeaulieuAbdelahad David,
Crawford Fiona,
Abdullah Laila,
Kenny Rose Anne,
Kennelly Sean,
Lawlor Brian,
Paris Daniel
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.09.124
Subject(s) - pharmacology , in vivo , chemistry , mechanism of action , neuroscience , in vitro , medicine , biology , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom